The Max Cure Foundation Inc

“Line 2 explanation - richard plotkin, vice chairman,is the father of david plotkin. Annmarie saracino plotkin is married to david plotkin. Elliot kervin is the son-in- law of richard plotkin.”

“Line 11a explanation - review for accuracy and compared to prior year”

“The foundation reviews its conflict of interest policy and where a question arises, consults with legal counsel and where aprropriate, seeks guidance from the board of directors.”

“At the board of directors meeting, the board voted and approved david plotkin's salary.”

“Upon request doucments are available for inspection”

“1. In 2014, the foundation contributed $1,020.00 to the memorial sloan - kettering cancer center, $4,500.00 to the ulman cancer fund, $600.00 to the philadelphia foundation, $500.00 to childrens cause for cancer and tenafly youth basketball and the sum of $50,047 to the families identified in paragraph 2, below. Also, based on the dunk your kicks compaign in 2014, $7,500 will be donated in august 2015 to memorial sloan kettering cancer center for the immune cell therapy lab supported by the foundation. 2. In 2014, the foundation made payments to 59 low income and military families battling pediatric cancer in the sum of $50,047 as part of its roar beyond barriers program. These families, whose children are in active cancer treatment, reside in 12 states at 21 hospitals throughout the country (the foundation is registered as a 501 (c) (3) in all states requiring such registrations to solicit funds in those states). Since the program was launched in november, 2011, over 85 families have been financialy assisted. Such assistance takes the form primarily of issuing to the families monthly gift cards from target stores to allow the families to buy necessities such as food and clothing. Medical expenses are otherwise covered for these families through medicaid or through state or federal unreimbursed medical cost programs. In addition to the monthly gift cards, on occasion the foundation assists the families by providing them with monies to pay certain bills in arrears (where there are threatened shutdowns, for example, of utility services) and also, by providing nutritional supplements needed to boost the child's immune system in such circumstances where the family would otherwise not be able to give the child such supplements given financial constraints being confronted by the family. The roar beyond barriers program continues to expand in 2015 so that by year end, it is hoped that the foundation will have included up to 100 families in the program since its launch, as noted, in november, 2011. 3. In 2013, foundation formed the angels fund as part of its roar beyond barriers program. The purpose of the angels fund is to contribute up to $500 towards the funeral expenses of children in the roar beyond barriers program who pass away from the disease. In 2014,no contributions were made or sought towards funeral costs of children in the program who died from the disease. 4. In 2013, richard plotkin, a member of the plotkin family who performs substantial services for the foundation as vice chairman and chief financial officer, does not receive a salary or any other compensation from the foundation. In 2014, he donated $220,257.00 to the foundation for its general unrestricted use. In addition, a substantial amount of costs which benefited the foundation were paid by richard for which he was not reimbursed by the foundation. 5. In 2014, mcf officially added advocacy to its mission to advance the cause of childhood cancers. Mcf has been in the forefront of the childhood cancer advocacy community since 2011 by relentlessly pursing legislation and regulatory changes that seek to benefit children diagnosed with cancer and at the same time, to raise awareness generally of issues applicable to childhood cancer. Of particular significance in 2014 is the case of josh hardy. Josh had experienced four bouts of kidney cancer from the age of 9 months and in january, 2014, at the age of 7, had a bone marrow transplant which resulted in his being diagnosed in mid-february with a life threatening adenovirus given his immune system was totally compromised. The available medications which had been approved by the fda and which were used in josh's treatment were not working and as of march 7, 2014 he was given two weeks to live unless, according to his treating doctors, he was given an experimental drug known as brincidofovir which was manufactured by chimerix, a bio tech firm in north carolina. Chimerix continued to decline the request by josh's treati”